Irina Koffler | LifeSci Advisors |
Spiro Rombotis | President and Chief Executive Officer |
Paul McBarron | Executive Vice President, Chief Financial Officer and Chief Operating Officer |
Mark Kirschbaum | Senior Vice President and Chief Medical Officer |
Ahu Demir | Ladenburg Thalmann & Co |
Jonathan Aschoff | ROTH Capital Partners |
Good afternoon, and welcome to the Cyclacel Pharmaceuticals Second Quarter 2022 Results Conference Call and Webcast. [Operator Instructions]. Please note, today's call is being recorded. I would now like to turn the conference call over to the company.
Good afternoon, everyone, and thank you for joining today's conference call to discuss Cyclacel's Financial Results and Business Highlights for the second quarter of 2022.